Showing results (1381-1390 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|May 26, 2020
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer modelPhilipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapyLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditionsZhenyuan Dong, Wesley A Cheng, D Lynne Smith, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2021
Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodiesMorinobu Seki, Shigehisa Kitano, Shigeaki Suzuki
Cancer Immunology, Immunotherapy : CII|February 23, 2023
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccinesCarmen Aguilar-Gurrieri, Ana Barajas, Carla Rovirosa, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturationYun-Shan Lin, Shu-Fen Chiang, Chia-Yi Chen, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2023
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanomaNathaniel Dasyam, Katrina J Sharples, Catherine Barrow, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2023
M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironmentMisato Ito, Kosaku Mimura, Shotaro Nakajima, et al.
Pageof 651